USPTO serial 88232337
4C PHARMA SOLUTIONS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 3, 2019
- Examiner
- WILKE, JOHN
- Law office
- Historical data usage
What this means
Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.
Need help with 4C PHARMA SOLUTIONS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Piscataway, NJ, US
Piscataway, NJ, US
Piscataway, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
ESTEBAN O'FARRELL
2125 Biscayne Blvd., Suite 206Miami, FL 33137United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics with governmental regulatory bodies; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for new drug, generic drug, medical device, drug/device combination, biologic, biosimilar, nutraceutical, consumer product or cosmetic approval; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics with governmental regulatory bodies; providing consulting services in the field of regulatory submission management to companies to assist them with applications for new drug, generic drug, medical device, drug/device combination, biologic, biosimilar, nutraceutical, consumer product or cosmetic approval; interactive record-keeping services for use in risk management and regulatory compliance by insurers and professionals in the medical field; business risk assessment services | ACTIVE | Sep 8, 2018 |
| 041 | Training services in the field of pharmacovigilance and regulatory compliance | ACTIVE | Sep 8, 2018 |
| 042 | Technical writing for others; technical writing in the field of medical writing; searching and retrieving information, sites, and other resources available on computer networks for others; consulting services for others in the field of design, planning, and implementation project management of clinical trials and pharmacovigilance; installation and maintenance of pharmacovigilance computer software; tracking and monitoring of safety and/or efficacy for drugs, devices, drug/device combinations, biologics, biosimilars, cosmetics, nutraceuticals or consumer products for others for pharmacovigilance purposes | ACTIVE | Sep 8, 2018 |
| 044 | Providing medical information in the field of pharmacovigilance and clinical trials | ACTIVE | Sep 8, 2018 |
| 045 | Regulatory compliance consulting in the field of prescription drug sampling; tracking and monitoring regulatory requirements in the field of new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics for regulatory compliance purposes; regulatory compliance consulting in the field of new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics | ACTIVE | Sep 8, 2018 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by 4C Pharma Solutions LLC
- Other trademarks owned by 4C Pharma Solutions LLC
- Other trademarks owned by 4C Pharma Solutions LLC
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named 4C PHARMA SOLUTIONS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 16, 2026 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Jun 16, 2026 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Jun 15, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 2, 2026 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Feb 27, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 27, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 27, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 27, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 27, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 3, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 3, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 18, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 18, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 29, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 15, 2019 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| May 10, 2019 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| May 3, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 3, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 3, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 3, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 3, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 3, 2019 | ZZAX | PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU | — |
| May 3, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 3, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 3, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 3, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 3, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 3, 2019 | ZZAX | PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU | — |
| May 3, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 2, 2019 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Apr 23, 2019 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Apr 11, 2019 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 10, 2019 | ALIE | ASSIGNED TO LIE | — |
| Mar 18, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 18, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 18, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 18, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 18, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 13, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 8, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 20, 2018 | NWAP | NEW APPLICATION ENTERED | — |